Trial
NCT04968184
Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
KBP Biosciences
Collaborators
—
Condition
Chronic Kidney Diseases
Intervention
Placebo
Why stopped
Interim futility analysis showed primary endpoint not achieved
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-03